These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 30470932)

  • 1. Fully automated real-time PCR for EGFR testing in non-small cell lung carcinoma.
    Colling R; Bancroft H; Langman G; Soilleux E
    Virchows Arch; 2019 Feb; 474(2):187-192. PubMed ID: 30470932
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of epidermal growth factor receptor mutation detection turnaround times and concordance among real-time polymerase chain reaction, high-throughput next-generation sequencing and the Biocartis Idylla™ platforms in non-small cell lung carcinomas.
    Sharma S; Satapathy A; Aggarwal A; Dewan A; Jain E; Katara R; Kumar V; Pal R; Pandey S; Naidu MM; Kini L; Pradhan D; Mohanty SK
    Pathol Res Pract; 2021 Apr; 220():153394. PubMed ID: 33706124
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Short report: Performance evaluation of the Idylla™ KRAS and EGFR mutation tests on paraffin-embedded cytological NSCLC samples.
    Offerman S; Prinsen CF; Knol A; Methorst N; Kamphorst J; Niemantsverdriet M
    Diagn Pathol; 2021 Aug; 16(1):70. PubMed ID: 34344387
    [TBL] [Abstract][Full Text] [Related]  

  • 4. FACILITATE: A real-world, multicenter, prospective study investigating the utility of a rapid, fully automated real-time PCR assay versus local reference methods for detecting epidermal growth factor receptor variants in NSCLC.
    Behnke A; Cayre A; De Maglio G; Giannini G; Habran L; Tarsitano M; Chetta M; Cappellen D; Lespagnol A; Le Naoures C; Massazza G; Destro A; Bonzheim I; Rau A; Battmann A; Kah B; Watkin E; Hummel M
    Pathol Oncol Res; 2023; 29():1610707. PubMed ID: 36798672
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical performance evaluation of the Idylla™ EGFR Mutation Test on formalin-fixed paraffin-embedded tissue of non-small cell lung cancer.
    Delgado-García M; Weynand B; Gómez-Izquierdo L; Hernández MJ; Blanco ÁM; Varela M; Matias-Guiu X; Nadal E; Márquez-Lobo B; Alarcão A; de Álava E; Biscuola M
    BMC Cancer; 2020 Apr; 20(1):275. PubMed ID: 32245434
    [TBL] [Abstract][Full Text] [Related]  

  • 6. EGFR Mutation Analysis in Non-small Cell Lung Carcinoma from Tissue Samples Using the Fully Automated Idylla™ qPCR System.
    Heeke S; Hofman P
    Methods Mol Biol; 2019; 2054():147-155. PubMed ID: 31482454
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rapid
    Al-Turkmani MR; Suriawinata MA; Deharvengt SJ; Green DC; Black CC; Shirai K; Dragnev KH; Tsongalis GJ
    Pract Lab Med; 2020 May; 20():e00156. PubMed ID: 32181314
    [TBL] [Abstract][Full Text] [Related]  

  • 8. EGFR and KRAS molecular genotyping for pulmonary carcinomas: Feasibility of a simple and rapid technique implementable in any department of pathology.
    Thomas De Montpréville V; Ghigna MR; Lacroix L; Lemoine A; Besse B; Mercier O; Fadel É; Dorfmuller P; Le Chevalier T;
    Pathol Res Pract; 2017 Jul; 213(7):793-798. PubMed ID: 28554746
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Feasibility analysis of rapid gene detection using intraoperative frozen tissues: comparison of intraoperative frozen tissues with paraffin-embedded tissues in epidermal growth factor receptor gene mutation detection of lung adenocarcinoma.
    Zhang JJ; Long ZB; Luo LL; Li LH; Yang H; Cao Y; Wang L; Wang WP
    J Cancer Res Clin Oncol; 2023 Oct; 149(13):12025-12032. PubMed ID: 37421459
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Microfluidics-based EGFR mutation detection and its implication in the resource-limited clinical setting.
    Joshi P; Gogte P; Pai T; Gurav M; Dhanawade D; Karnik N; Deshpande G; Kaushal R; Shetty O
    Int J Exp Pathol; 2024 Jun; 105(3):90-99. PubMed ID: 38717047
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Integrating the Idylla™ System Alongside a Real-Time Polymerase Chain Reaction and Next-Generation Sequencing for Investigating Gene Fusions in Pleural Effusions from Non-Small-Cell Lung Cancer Patients: A Pilot Study.
    Scarpino S; Leone A; Galafate D; Pepe F; Malapelle U; Villani S; Giarnieri E; Maurizi G; De Vitis C; Mancini R; Mancini M; Di Napoli A; Vecchione A; Pilozzi E
    Int J Mol Sci; 2024 Jul; 25(14):. PubMed ID: 39062837
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of targeted next-generation sequencing (NGS) and real-time PCR in the detection of EGFR, KRAS, and BRAF mutations on formalin-fixed, paraffin-embedded tumor material of non-small cell lung carcinoma-superiority of NGS.
    Tuononen K; Mäki-Nevala S; Sarhadi VK; Wirtanen A; Rönty M; Salmenkivi K; Andrews JM; Telaranta-Keerie AI; Hannula S; Lagström S; Ellonen P; Knuuttila A; Knuutila S
    Genes Chromosomes Cancer; 2013 May; 52(5):503-11. PubMed ID: 23362162
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeted methods for molecular characterization of EGFR mutational profile in lung cancer Moroccan cohort.
    Kaanane H; El Attar H; Louahabi A; ; Berradi H; Idrissi HH; Khyatti M; Nadifi S
    Gene; 2019 Jul; 705():36-43. PubMed ID: 31004715
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ultra-rapid Idylla™
    Qiu T; Zhang F; Zheng B; Feng Z; Li W; Zeng H; Chu L; Ying J
    Front Oncol; 2023; 13():1064487. PubMed ID: 37064089
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of rare and novel EGFR mutations in NSCLC patients: Implications for treatment-decision.
    Sousa AC; Silveira C; Janeiro A; Malveiro S; Oliveira AR; Felizardo M; Nogueira F; Teixeira E; Martins J; Carmo-Fonseca M
    Lung Cancer; 2020 Jan; 139():35-40. PubMed ID: 31715539
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multicenter Evaluation of the Fully Automated PCR-Based Idylla EGFR Mutation Assay on Formalin-Fixed, Paraffin-Embedded Tissue of Human Lung Cancer.
    Evrard SM; Taranchon-Clermont E; Rouquette I; Murray S; Dintner S; Nam-Apostolopoulos YC; Bellosillo B; Varela-Rodriguez M; Nadal E; Wiedorn KH; Melchior L; Andrew E; Jones M; Ridgway J; Frykman C; Lind L; Rot M; Kern I; Speel EJM; Roemen GMJM; Trincheri N; Freiberger SN; Rechsteiner M
    J Mol Diagn; 2019 Nov; 21(6):1010-1024. PubMed ID: 31445213
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comprehensive analysis of NGS and ARMS-PCR for detecting EGFR mutations based on 4467 cases of NSCLC patients.
    He C; Wei C; Wen J; Chen S; Chen L; Wu Y; Shen Y; Bai H; Zhang Y; Chen X; Li X
    J Cancer Res Clin Oncol; 2022 Feb; 148(2):321-330. PubMed ID: 34693477
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Detection of EGFR gene mutations in 100 non-small cell lung cancer clinical samples by a real-time polymerase chain reaction method using amplification refractory mutation system specific primers and Taqman fluorescence probes].
    Zhao J; Zhao J; Zhao X; Chen W; Zhong W; Zhang L; Li L; Wang M
    Zhongguo Fei Ai Za Zhi; 2013 Jan; 16(1):25-32. PubMed ID: 23327870
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Screening for EGFR and KRAS mutations in non-small cell lung carcinomas using DNA extraction by hydrothermal pressure coupled with PCR-based direct sequencing.
    Liu Y; Wu BQ; Zhong HH; Hui P; Fang WG
    Int J Clin Exp Pathol; 2013; 6(9):1880-9. PubMed ID: 24040454
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analytic performance studies and clinical reproducibility of a real-time PCR assay for the detection of epidermal growth factor receptor gene mutations in formalin-fixed paraffin-embedded tissue specimens of non-small cell lung cancer.
    O'Donnell P; Ferguson J; Shyu J; Current R; Rehage T; Tsai J; Christensen M; Tran HB; Chien SS; Shieh F; Wei W; Lawrence HJ; Wu L; Schilling R; Bloom K; Maltzman W; Anderson S; Soviero S
    BMC Cancer; 2013 Apr; 13():210. PubMed ID: 23621958
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.